Eton Pharmaceuticals, Inc. financial data

Symbol
ETON on Nasdaq
Industry
Pharmaceutical Preparations
Location
21925 W. Field Parkway, Suite 235, Deer Park, IL
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 153 % -44%
Quick Ratio 10.4 % +23.5%
Debt-to-equity 116 % +25.1%
Return On Equity -36.3 % -335%
Return On Assets -16.8 % -310%
Operating Margin -15.1 % -365%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 25.8M shares +0.69%
Common Stock, Shares, Outstanding 25.8M shares +0.69%
Entity Public Float 84.7M USD +64.5%
Common Stock, Value, Issued 26K USD 0%
Weighted Average Number of Shares Outstanding, Basic 25.6M shares +1.99%
Weighted Average Number of Shares Outstanding, Diluted 26.6K shares +3.23%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 34.7M USD +5.64%
Research and Development Expense 5.17M USD +60.7%
General and Administrative Expense 20.6M USD +10.2%
Operating Income (Loss) -5.22M USD -380%
Nonoperating Income (Expense) -87K USD -124%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -5.31M USD -338%
Income Tax Expense (Benefit) 175K USD
Net Income (Loss) Attributable to Parent -5.48M USD -346%
Earnings Per Share, Basic -0.23 USD/shares -100%
Earnings Per Share, Diluted 0.02 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 20.3M USD -8.2%
Accounts Receivable, after Allowance for Credit Loss, Current 5.59M USD +60%
Inventory, Net 1.94M USD +84.4%
Assets, Current 29.7M USD +9.55%
Property, Plant and Equipment, Net 33K USD -13.2%
Operating Lease, Right-of-Use Asset 193K USD +77.1%
Intangible Assets, Net (Excluding Goodwill) 5.85M USD +39.1%
Other Assets, Noncurrent 12K USD 0%
Assets 35.8M USD +13.7%
Accounts Payable, Current 2.68M USD +56.8%
Accrued Liabilities, Current 11.4M USD +98.8%
Liabilities, Current 19.7M USD +89.9%
Operating Lease, Liability, Noncurrent 126K USD +186%
Liabilities 19.9M USD +35.7%
Retained Earnings (Accumulated Deficit) -107M USD -5.38%
Stockholders' Equity Attributable to Parent 16M USD -5.39%
Liabilities and Equity 35.8M USD +13.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.47M USD -59.8%
Net Cash Provided by (Used in) Financing Activities -378K USD -671%
Net Cash Provided by (Used in) Investing Activities -1.88M USD
Common Stock, Shares Authorized 50M shares 0%
Common Stock, Shares, Issued 25.8M shares +0.69%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -4.73M USD -196%
Interest Paid, Excluding Capitalized Interest, Operating Activities 190K USD -12%
Deferred Tax Assets, Valuation Allowance 21.5M USD -0.54%
Deferred Tax Assets, Gross 21.5M USD -0.54%
Operating Lease, Liability 201K USD +114%
Depreciation 50K USD +11.1%
Payments to Acquire Property, Plant, and Equipment 14K USD
Lessee, Operating Lease, Liability, to be Paid 225K USD +118%
Property, Plant and Equipment, Gross 467K USD +10.9%
Operating Lease, Liability, Current 75K USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 90K USD +291%
Lessee, Operating Lease, Liability, to be Paid, Year One 89K USD -1.11%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 24K USD +167%
Lessee, Operating Lease, Liability, to be Paid, Year Three 23K USD
Deferred Tax Assets, Operating Loss Carryforwards 15.4M USD -10.1%
Unrecognized Tax Benefits 0 USD
Operating Lease, Payments 10K USD -54.5%
Amortization of Intangible Assets 1M USD -50.6%
Depreciation, Depletion and Amortization 66K USD -57.4%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 2.38M USD -0.17%
Interest Expense 211K USD -21%